Kook SH et al. |
Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. |
2005 |
J. Biochem. Mol. Biol. |
pmid:16336792
|
Burlibaşa L and Gavrilă L |
Molecular and ultrastructural studies of the sperm chromatin from Triturus cristatus. |
2005 |
Zygote |
pmid:16261764
|
Marengo E et al. |
Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. |
2005 |
J Chromatogr A |
pmid:16301071
|
Juranek SA et al. |
snRNA and heterochromatin formation are involved in DNA excision during macronuclear development in stichotrichous ciliates. |
2005 |
Eukaryotic Cell |
pmid:16278460
|
Xiong Y et al. |
Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. |
2005 |
Gynecol. Oncol. |
pmid:16024066
|
Xu CR et al. |
Histone acetylation affects expression of cellular patterning genes in the Arabidopsis root epidermis. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16176989
|
Wu P et al. |
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:16051188
|
Yaneva M et al. |
Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. |
2005 |
Nucleic Acids Res. |
pmid:16177181
|
Kang JE et al. |
Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1. |
2005 |
Cell. Physiol. Biochem. |
pmid:16121030
|
Chen CS et al. |
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. |
2005 |
J. Biol. Chem. |
pmid:16186112
|
Bradbury CA et al. |
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. |
2005 |
Leukemia |
pmid:16121216
|
Cismasiu VB et al. |
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. |
2005 |
Oncogene |
pmid:16091750
|
Gurvich N et al. |
Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. |
2005 |
FASEB J. |
pmid:15901671
|
Sengupta S et al. |
Tumor suppressor p53 represses transcription of RECQ4 helicase. |
2005 |
Oncogene |
pmid:15674334
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|
Seo H et al. |
Rapid generation of specific antibodies by enhanced homologous recombination. |
2005 |
Nat. Biotechnol. |
pmid:15924134
|
Song Y et al. |
[The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15854272
|
Xu ZM et al. |
[Analysis of the methylation in the promoter of LRP15 gene and its expression]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15854274
|
Mai A et al. |
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. |
2005 |
J. Med. Chem. |
pmid:15857140
|
Ho WC et al. |
Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. |
2005 |
Cancer Res. |
pmid:15899819
|
Mori T et al. |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. |
2005 |
Cancer Res. |
pmid:15753377
|
Dowling M et al. |
Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. |
2005 |
Cancer Biol. Ther. |
pmid:15753652
|
Dote H et al. |
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. |
2005 |
Br. J. Cancer |
pmid:15770214
|
Laberge RM and Boissonneault G |
On the nature and origin of DNA strand breaks in elongating spermatids. |
2005 |
Biol. Reprod. |
pmid:15772260
|
Kawano T et al. |
Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. |
2004 Sep-Oct |
Anticancer Res. |
pmid:15517875
|
Fenic I et al. |
In vivo effects of histone-deacetylase inhibitor trichostatin-A on murine spermatogenesis. |
2004 Sep-Oct |
J. Androl. |
pmid:15292114
|
Emionite L et al. |
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736447
|
Karasawa Y and Okisaka S |
Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells. |
2004 Nov-Dec |
Jpn. J. Ophthalmol. |
pmid:15592778
|
Hildmann C et al. |
A new amidohydrolase from Bordetella or Alcaligenes strain FB188 with similarities to histone deacetylases. |
2004 |
J. Bacteriol. |
pmid:15060035
|
Vorontsova M et al. |
Effect of 5-azacytidine and trichostatin A on somatic centromere association in wheat. |
2004 |
Genome |
pmid:15060593
|
Tong X et al. |
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15063780
|
Kurtev V et al. |
Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. |
2004 |
J. Biol. Chem. |
pmid:15140878
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Klampfer L et al. |
Requirement of histone deacetylase activity for signaling by STAT1. |
2004 |
J. Biol. Chem. |
pmid:15123634
|
Fu M et al. |
The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. |
2004 |
J. Biol. Chem. |
pmid:15123687
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Iezzi S et al. |
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. |
2004 |
Dev. Cell |
pmid:15130492
|
Bort R et al. |
Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes. |
2004 |
Arch. Biochem. Biophys. |
pmid:15130783
|
Brush MH et al. |
Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. |
2004 |
J. Biol. Chem. |
pmid:14670976
|
Lee JH et al. |
Histone deacetylase activity is required for embryonic stem cell differentiation. |
2004 |
Genesis |
pmid:14755802
|
Lemonde S et al. |
Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. |
2004 |
J. Neurochem. |
pmid:14756806
|
Hattori N et al. |
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. |
2004 |
J. Biol. Chem. |
pmid:14761969
|
Liu X et al. |
Nuclear factor Y regulation and promoter transactivation of human ribonucleotide reductase subunit M2 gene in a Gemcitabine resistant KB clone. |
2004 |
Biochem. Pharmacol. |
pmid:15041467
|
Christian M et al. |
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. |
2004 |
J. Biol. Chem. |
pmid:14736873
|
Mai A et al. |
3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity. |
2004 |
J. Med. Chem. |
pmid:14971890
|
Nishikawa J et al. |
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. |
2004 |
Virus Genes |
pmid:14739656
|
Milhem M et al. |
Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. |
2004 |
Blood |
pmid:14976039
|
Wang DF et al. |
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14741273
|
Agostinho M et al. |
Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. |
2004 |
Mol. Biol. Cell |
pmid:14978217
|
Sakata R et al. |
Trichostatin A activates the osteopontin gene promoter through AP1 site. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14985105
|
Knobbe CB et al. |
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. |
2004 |
J. Natl. Cancer Inst. |
pmid:15026474
|
Yan C et al. |
A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. |
2004 |
FASEB J. |
pmid:14715692
|
Chung YL et al. |
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. |
2004 |
Mol. Cancer Ther. |
pmid:15026552
|
Zelko IN and Folz RJ |
Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase. |
2004 |
Free Radic. Biol. Med. |
pmid:15451065
|
Steiner E et al. |
SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15047174
|
Kypreou KP et al. |
Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A. |
2004 |
Exp. Gerontol. |
pmid:15050280
|
Cao H et al. |
Induction of human gamma globin gene expression by histone deacetylase inhibitors. |
2004 |
Blood |
pmid:12920038
|
Sarg B et al. |
Histone H4 hyperacetylation precludes histone H4 lysine 20 trimethylation. |
2004 |
J. Biol. Chem. |
pmid:15456746
|
Nan X et al. |
Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15465025
|
Lee HS et al. |
Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. |
2004 |
Biol. Pharm. Bull. |
pmid:15467184
|
Sangster-Guity N et al. |
Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment. |
2004 |
Cancer Biol. Ther. |
pmid:15467438
|
Alcendor RR et al. |
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. |
2004 |
Circ. Res. |
pmid:15486319
|
Gius D et al. |
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. |
2004 |
Cancer Cell |
pmid:15488759
|
De La Fuente R et al. |
Major chromatin remodeling in the germinal vesicle (GV) of mammalian oocytes is dispensable for global transcriptional silencing but required for centromeric heterochromatin function. |
2004 |
Dev. Biol. |
pmid:15501230
|
Lin AC et al. |
The N termini of Friend of GATA (FOG) proteins define a novel transcriptional repression motif and a superfamily of transcriptional repressors. |
2004 |
J. Biol. Chem. |
pmid:15507435
|
Wang S and Zhu J |
The hTERT gene is embedded in a nuclease-resistant chromatin domain. |
2004 |
J. Biol. Chem. |
pmid:15516693
|
Yamashita Y et al. |
cDNA microarray analysis in hepatocyte differentiation in Huh 7 cells. |
2004 |
Cell Transplant |
pmid:15690981
|
GarcÃa I et al. |
Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. |
2004 |
Eukaryotic Cell |
pmid:14871945
|
Takai N et al. |
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. |
2004 |
Clin. Cancer Res. |
pmid:14871994
|
Ronai D et al. |
The epigenetic stability of the locus control region-deficient IgH locus in mouse hybridoma cells is a clonally varying, heritable feature. |
2004 |
Genetics |
pmid:15166165
|
Zhang X et al. |
Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3. |
2004 |
Mol. Cell. Biol. |
pmid:15169878
|
Ishiguro K and Sartorelli AC |
Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A. |
2004 |
Eur. J. Biochem. |
pmid:15182353
|
Brieger A et al. |
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors. |
2004 |
Biochem. Pharmacol. |
pmid:15183120
|
Shim JS et al. |
Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. |
2004 |
Oncogene |
pmid:14661058
|
Tang XX et al. |
Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. |
2004 |
Clin. Cancer Res. |
pmid:15355914
|
Yokota T et al. |
Trichostatin A activates p18INK4c gene: differential activation and cooperation with p19INK4d gene. |
2004 |
FEBS Lett. |
pmid:15358560
|
Boehrer S et al. |
In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis. |
2004 |
Leuk. Lymphoma |
pmid:15359646
|
Vaghefi H and Neet KE |
Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. |
2004 |
Oncogene |
pmid:15361854
|
Moore PS et al. |
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. |
2004 |
Biochim. Biophys. Acta |
pmid:15363630
|
Chiba T et al. |
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. |
2004 |
J. Hepatol. |
pmid:15336447
|
Liu CJ et al. |
Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. |
2004 |
J. Biol. Chem. |
pmid:15337766
|
Cosio BG et al. |
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. |
2004 |
J. Exp. Med. |
pmid:15337792
|
Iijima K et al. |
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid. |
2004 |
Leuk. Lymphoma |
pmid:15291362
|
Tóth KF et al. |
Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. |
2004 |
J. Cell. Sci. |
pmid:15292402
|
Myzak MC et al. |
A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. |
2004 |
Cancer Res. |
pmid:15313918
|
Munro J et al. |
Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. |
2004 |
Exp. Cell Res. |
pmid:15093749
|
Ishihara K et al. |
Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils. |
2004 |
Br. J. Pharmacol. |
pmid:15210580
|
Marengo E et al. |
Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis. |
2004 |
Anal Bioanal Chem |
pmid:15257427
|
Schauber J et al. |
Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. |
2004 |
Mol. Immunol. |
pmid:15261456
|
De La Fuente R et al. |
ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. |
2004 |
Dev. Biol. |
pmid:15242786
|
Fang JY et al. |
Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. |
2004 |
Cell Res. |
pmid:15225415
|
Banwell CM et al. |
Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. |
2004 |
J. Steroid Biochem. Mol. Biol. |
pmid:15225779
|
Mao DY et al. |
Promoter-binding and repression of PDGFRB by c-Myc are separable activities. |
2004 |
Nucleic Acids Res. |
pmid:15226411
|
Naruse Y et al. |
Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. |
2004 |
Mol. Cell. Biol. |
pmid:15226430
|
Alao JP et al. |
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. |
2004 |
Clin. Cancer Res. |
pmid:15585645
|
Chen WK et al. |
[Effect of trichostatin A on histone acetylation level and apoptosis in HL-60 cells]. |
2004 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15228659
|
Kim JH et al. |
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. |
2004 |
Int. J. Radiat. Oncol. Biol. Phys. |
pmid:15234053
|
Sakamoto S et al. |
Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. |
2004 |
J. Biol. Chem. |
pmid:15194680
|
Ng Y et al. |
Expression of the human myotonic dystrophy kinase-related Cdc42-binding kinase gamma is regulated by promoter DNA methylation and Sp1 binding. |
2004 |
J. Biol. Chem. |
pmid:15194684
|
Lu H et al. |
Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. |
2004 |
J. Virol. |
pmid:15194748
|